Publication: Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
JAIDS Journal of Acquired Immune Deficiency Syndromes
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Treasure, Graham C., Evgenia Aga, Ronald J. Bosch, John W. Mellors, Daniel R. Kuritzkes, Michael Para, Rajesh T. Gandhi, and Jonathan Z. Li. 2016. “Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.” Journal of Acquired Immune Deficiency Syndromes (1999) 72 (3): 310-313. doi:10.1097/QAI.0000000000000964. http://dx.doi.org/10.1097/QAI.0000000000000964.
Research Data
Abstract
Abstract: Viral load (VL) rebound timing and set point were analyzed in 235 participants undergoing analytic treatment interruption (ATI) in 6 AIDS Clinical Trials Group studies. There was no significant association between rebound timing and ATI VL set point for those who rebounded ≤12 weeks. VL set points were lower in participants with rebound >12 weeks (P < 0.001) and participants treated during early infection (P < 0.001). Pre-antiretroviral therapy VL correlated with set point, though 68% of participants had a set point lower than pre-antiretroviral therapy VL. These results illustrate complex relationships between post-ATI virologic outcomes and the potential presence of biological factors mediating rebound timing and set point.
Description
Other Available Sources
Keywords
HIV, treatment interruption, set point, viral rebound, outcome
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service